{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T00:23:27Z","timestamp":1792887807518,"version":"4.5.0"},"reference-count":39,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2011,7,6]],"date-time":"2011-07-06T00:00:00Z","timestamp":1309910400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0021296","type":"journal-article","created":{"date-parts":[[2011,7,6]],"date-time":"2011-07-06T20:52:12Z","timestamp":1309985532000},"page":"e21296","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":113,"title":["SMA CARNI-VAL TRIAL PART II: A Prospective, Single-Armed Trial of L-Carnitine and Valproic Acid in Ambulatory Children with Spinal Muscular Atrophy"],"prefix":"10.1371","volume":"6","author":[{"given":"John T.","family":"Kissel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles B.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra P.","family":"Reyna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas O.","family":"Crawford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise R.","family":"Simard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin J.","family":"Krosschell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gyula","family":"Acsadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bakri","family":"Elsheik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary K.","family":"Schroth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"D'Anjou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"LaSalle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas W.","family":"Prior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Sorenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo Anne","family":"Maczulski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark B.","family":"Bromberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary M.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn J.","family":"Swoboda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the Project Cure Spinal Muscular Atrophy Investigators' Network","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2011,7,6]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s001090050059","article-title":"Spinal muscular atrophies: recent insights and impact on molecular diagnosis.","volume":"74","author":"C Brahe","year":"2006","journal-title":"J Mol Med"},{"issue":"239","key":"ref2","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1136\/adc.45.239.33","article-title":"The genetic component in child mortality.","volume":"45","author":"DF Roberts","year":"1970","journal-title":"Arch Dis Child"},{"issue":"6","key":"ref3","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1136\/jmg.15.6.409","article-title":"Incidence, prevalence, and gene frequency studies of chronic childhood spinal muscular atrophy.","volume":"15","author":"J Pearn","year":"1978","journal-title":"J Med Genet"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1136\/jmg.26.12.761","article-title":"A Hungarian study on Werdnig-Hoffmann disease.","volume":"26","author":"A Czeizel","year":"1989","journal-title":"J Med Genet"},{"issue":"1","key":"ref5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0960-8966(91)90039-U","article-title":"Population frequencies of inherited neuromuscular diseases\u2013a world survey.","volume":"1","author":"AE Emery","year":"1991","journal-title":"Neuromuscul Disord"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0960-8966(92)90006-R","article-title":"Epidemiology of neuromuscular disorders in the under-20 population in Bologna Province, Italy.","volume":"2","author":"L Merlini","year":"1992","journal-title":"Neuromuscul Disord"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","article-title":"Identification and Characterization of a Spinal Muscular Atrophy-determining Gene.","volume":"80","author":"S Lefebvre","year":"1995","journal-title":"Cell"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1086\/302369","article-title":"Quantitative analysis of survival motor neuron copies: identification of subtle SMN1 mutation in patients with spinal muscular atrophy, genotype-phenotype correlation, and implications for genetic counseling.","volume":"64","author":"B Wirth","year":"1999","journal-title":"Am J Hum Genet"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"5543","DOI":"10.1128\/MCB.25.13.5543-5551.2005","article-title":"The survival of motor neurons protein determines the capacity for snRNP assembly: biochemical deficiency in spinal muscular atrophy.","volume":"25","author":"L Wan","year":"1995","journal-title":"Mol Cell Biol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"6307","DOI":"10.1073\/pnas.96.11.6307","article-title":"A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy.","volume":"96","author":"CL Lorson","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nrn2670","article-title":"Spinal muscular atrophy: why do low levels of survival motor neuron protein make motor neurons sick?","volume":"10","author":"AHM Burghes","year":"2009","journal-title":"Nature Reviews Neuroscience"},{"issue":"2","key":"ref12","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1086\/338627","article-title":"Quantitative analyses of SMN1 and SMN2 based on real-time lightcycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy.","volume":"70","author":"M Feldkotter","year":"2002","journal-title":"Am J Hum Genet"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/00125817-200201000-00004","article-title":"Molecular analysis of spinal muscular atrophy and modification of the phenotype by SMN2.","volume":"4","author":"MD Mailman","year":"2002","journal-title":"Genet Med"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/ana.20473","article-title":"Natural history of denervation in SMA: relation to age, SMN2 copy number, and function.","volume":"57","author":"KJ Swoboda","year":"2005","journal-title":"Ann Neurol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1007\/s00439-006-0156-7","article-title":"Mildly affected patients with spinal muscular atrophy are partially protected by an increased SMN2 copy number.","volume":"119","author":"B Wirth","year":"2006","journal-title":"Hum Genet"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/ajmg.a.30251","article-title":"Homozygous SMN1 deletions in unaffected family members and modification of the phenotype by SMN2.","volume":"130","author":"TW Prior","year":"2004","journal-title":"Am J Med Genet A"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/ng0797-265","article-title":"Correlation between severity and SMN protein level in spinal muscular atrophy.","volume":"1997; 16","author":"S Lefebvre","year":"1997","journal-title":"Nat Genet"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.ajhg.2009.08.002","article-title":"A positive modifier of spinal muscular atrophy in the SMN2 gene.","volume":"85","author":"TW Prior","year":"2009","journal-title":"Am J Hum Gen"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1126\/science.1155085","article-title":"Plastin 3 is a protective modifier of autosomal recessive spinal muscular atrophy.","volume":"320","author":"GE Oprea","year":"2008","journal-title":"Science"},{"issue":"28","key":"ref20","doi-asserted-by":"crossref","first-page":"7502","DOI":"10.1523\/JNEUROSCI.0096-06.2006","article-title":"Endogenous \u03b1-synuclein is induced by valproic acid through histone deacetylase inhibition and participates in neuroprotection against glutamate-induced excitotoxicity.","volume":"26","author":"Y Leng","year":"2006","journal-title":"J Neurosci"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1747-0285.2006.00369.x","article-title":"Valproic acid promotes neurite outgrowth in PC12 cells independent from regulation of the survival of motoneuron protein.","volume":"67","author":"J van Bergeijk","year":"2006","journal-title":"Chem Biol Drug Des"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1111\/j.1460-9568.2004.03765.x","article-title":"Benefit of valproic acid in suppressing disease progression of ALS model mice.","volume":"20","author":"F Sugai","year":"2004","journal-title":"Eur J Neurosci"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1093\/hmg\/ddg256","article-title":"Valproic acid increases the SMN2 protein level: a well-known drug as a potential therapy for spinal muscular atrophy.","volume":"12","author":"L Brichta","year":"2003","journal-title":"Hum Mol Genet"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/ana.10743","article-title":"Valproic acid increases SMN levels in spinal muscular atrophy patient cells.","volume":"54","author":"CJ Sumner","year":"2003","journal-title":"Ann Neurol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1002\/ana.20836","article-title":"In vivo activation of SMN in spinal muscular atrophy carriers and patients treated with valproate.","volume":"59","author":"L Brichta","year":"2006","journal-title":"Ann Neurol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1093\/hmg\/ddi130","article-title":"The role of histone acetylation in SMN gene expression.","volume":"14","author":"LE Kernochan","year":"2005","journal-title":"Hum Mol Genet"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.nbd.2006.07.004","article-title":"Establishing a standardized therapeutic testing protocol for spinal muscular atrophy.","volume":"24","author":"LK Tsai","year":"2006","journal-title":"Neurobiol Dis"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1007\/s00109-008-0388-1","article-title":"Multiple therapeutic effects of valproic acid in spinal muscular atrophy model mice.","volume":"86","author":"LK Tsai","year":"2008","journal-title":"J Mol Med"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1212\/01.wnl.0000231139.26253.d0","article-title":"Valproate may improve strength and function in patients with type III\/IV spinal muscular atrophy.","volume":"67","author":"CC Weihl","year":"2006","journal-title":"Neurology"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1111\/j.1468-1331.2007.01992.x","article-title":"Valproic acid treatment in six patients with spinal muscular atrophy.","volume":"14","author":"LK Tsai","year":"2007","journal-title":"Eur J Neurol"},{"issue":"5","key":"ref31","doi-asserted-by":"crossref","first-page":"e5268","DOI":"10.1371\/journal.pone.0005268","article-title":"Phase II open label study of valproic acid in spinal muscular atrophy.","volume":"4","author":"KJ Swoboda","year":"2009","journal-title":"PLoS ONE"},{"key":"ref32","article-title":"SMA CARNI-VAL Trial part 1: double-blind, randomized, placebo-controlled trial of L-carnitine and valproic acid in spinal muscular atrophy.","author":"KJ Swoboda","year":"2010","journal-title":"PLoS One"},{"issue":"7","key":"ref33","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.nmd.2006.03.015","article-title":"A modified Hammersmith functional motor scale for use in multi-center research on spinal muscular atrophy.","volume":"16","author":"KJ Krosschell","year":"2006","journal-title":"Neuromuscul Disord"},{"key":"ref34","first-page":"1","article-title":"Literature review: health-related quality of life measurement in pediatric oncology: hearing the voices of the children.","author":"JW Varni","year":"2007","journal-title":"J Ped Psychol"},{"issue":"5","key":"ref35","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0960-8966(01)00193-6","article-title":"Reference values of maximum isometric muscle force obtained in 270 children aged 4\u201316 years by hand-held dynamometry.","volume":"11","author":"EA Beenakker","year":"2001","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"ref36","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/mus.10166","article-title":"Reliability of hand-held dynamometry in spinal muscular atrophy.","volume":"26","author":"L Merlini","year":"2002","journal-title":"Muscle Nerve"},{"issue":"2","key":"ref37","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/J006v22n02_05","article-title":"Review of the reliability and validity of myometry with children.","volume":"22","author":"C Sloan","year":"2002","journal-title":"Phys Occup Ther Pediatr"},{"issue":"6","key":"ref38","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.nmd.2009.03.009","article-title":"Increased fat mass and high incidence of overweitht despite low body mass index in patients with spinal muscular atrophy.","volume":"19","author":"DM Sproule","year":"2009","journal-title":"Neuromuscul Disord"},{"issue":"7","key":"ref39","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.nmd.2010.05.013","article-title":"Adiposity is increased among high-functioning, non-ambulatory patients with spinal muscular atrophy.","volume":"20","author":"DM Sroule","year":"2010","journal-title":"Neuromuscul Disord"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0021296","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T16:15:16Z","timestamp":1540224916000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0021296"}},"subtitle":[],"editor":[{"given":"Mel B.","family":"Feany","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,7,6]]},"references-count":39,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2011,7,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0021296","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7,6]]}}}